Contrast-Free Detection of Focused Ultrasound-Induced Blood-Brain Barrier Opening Using Diffusion Tensor Imaging.
Authors: Karakatsani ME, Pouliopoulos AN, Liu M, Jambawalikar SR, Konofagou EE
Focused ultrasound (FUS) has emerged as a non-invasive technique to locally and reversibly disrupt the blood-brain barrier (BBB). Here, we investigate the use of diffusion tensor imaging (DTI) as a means of detecting FUS-induced BBB opening at the absence of an MRI contrast agent. A non-human primate (NHP) was repeatedly treated with FUS and preformed circulating microbubbles to transiently disrupt the BBB (n = 4). T1- and diffusion-weighted MRI scans were acquired after the ultrasound treatment, with and without gadolinium-based contrast agent, respectively. Both scans were registered with a high-resolution T1-weighted scan of the NHP to investigate signal correlations. DTI detected an increase in fractional anisotropy from 0.21 ± 0.02 to 0.38 ± 0.03 (82.6 ± 5.2% change) within the targeted area one hour after BBB opening. Enhanced DTI contrast overlapped by 77.22 ± 9.2% with hyper-intense areas of gadolinium-enhanced T1-weighted scans, indicating diffusion anisotropy enhancement only within the BBB opening volume. Diffusion was highly anisotropic and unidirectional within the treated brain region, as indicated by the direction of the principal diffusion eigenvectors. Polar and azimuthal angle ranges decreased by 35.6% and 82.4%, respectively, following BBB opening. Evaluation of the detection methodology on a second NHP (n = 1) confirmed the across-animal feasibility of the technique. In conclusion, DTI may be used as a contrast-free MR imaging modality in lieu of contrast-enhanced T1 mapping for detecting BBB opening during focused-ultrasound treatment or evaluating BBB integrity in brain-related pathologies.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To evaluate whether diffusion tensor imaging can detect focused ultrasound–induced transient blood-brain barrier opening without using MRI contrast agents.
Animal model / Human subject
non-human primate, not specified, not specified, not specified
Disease model
healthy
MRI or image guidance method
MRI-guided
Targeted brain region(s)
Brain
Cargo name and characteristics
drug
Route of administration
intravenous
Outcomes and Safety
Summary of Outcomes
FUS with microbubbles induced transient BBB opening in non-human primates, detectable by diffusion tensor imaging.
Duration of biological effect
1 hour
Safety-related matter
No adverse effects reported.
Brain Region
Ultrasound Parameters
Ultrasound instrument
not reported
FUS Frequency
not reported
FUS Intensity
not reported
FUS Pressure
not reported
FUS Mode
not reported
Pulse duration
not reported
Duration of a single FUS session
not reported
Treatment frequency
Multiple sessions
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search